Deals

Tempus AI's $1.9 billion Personalis buy heads to a Nov 30 vote, paid in Tempus stock with up to half in cash

The $1.9 billion Personalis deal goes to a shareholder vote on November 30 with regulatory review already closed, and the filing shows Tempus pays in its own stock with up to half in cash, against $854 million on its balance sheet.

Vincent JiangVincent Jiangtwo-minute read
Share
Head and shoulders portrait of Eric Lefkofsky, co-founder and chief executive of Tempus AI, wearing glasses, a white shirt and a gold tie
Eric Lefkofsky, Tempus AI's co-founder and chief executive. Personalis shareholders vote on November 30 on Tempus's $1.9 billion purchase of their company.

Personalis shareholders vote on November 30, 2026, on the $1.9 billion sale of their cancer-testing company to Tempus AI−6.06% — Tempus AI, down 6.06 percent today, the Chicago diagnostics and clinical-data firm, and the filing behind that vote shows exactly who writes the check 2. Regulatory review is already complete, Tempus told its Q3 earnings call on November 15 2. The consideration is Tempus stock, with up to half payable in cash at Tempus's election, decided as late as three business days before closing 3.

The maximum cash election tops the bank account

Half of the $1,920 million equity value is about $960 million in cash, against $854 million of cash and marketable securities Tempus held at September 30 2. Even the maximum cash election tops the balance sheet, and Personalis brings $213 million of its own cash, trimming the net enterprise cost to $1,709 million 3. Management told the call that operating cash flow and existing liquidity should fund both growth and the acquisition 2, but the arithmetic leaves little slack, and Tempus has burned cash in most recent quarters.

Tempus burned operating cash in eight of the last ten quarters

-$150M-$100M-$50M$0M$50MQ3 '24Q1 '25Q3 '25Q1 '26Q3 '26$9.22M
Data
Operating cash flow
Q2 '24-$97.08M
Q3 '24$48.66M
Q4 '24-$39.25M
Q1 '25-$105.62M
Q2 '25$44.16M
Q3 '25-$119.84M
Q4 '25-$36.79M
Q1 '26-$73.28M
Q2 '26-$7.52M
Q3 '26$9.22M
USD millions; quarterly operating cash flow as reported in Tempus AI's SEC filings, retrieved 16 November 2026. Bars below zero are cash used in operations. Q3 2026 is the first positive quarter since Q2 2025.4

The collar moves the price risk onto Tempus holders

Below a $48.42 floor, the exchange ratio locks at 0.3356, so Tempus issues more shares as its stock falls; Personalis can walk away below $46.00 3. Tempus traded below the lower floor on announcement day 3. Stock consideration means roughly 14.8 percent pro forma dilution 3, and a fixed $16.25 per share goes to Personalis holders either way. Tempus also pays at 15.2x EV to forward revenue, about 2.4 times the diagnostic-deal median its own bankers cited 3, and it is buying a business that loses money on every MRD test, with only 15 percent of its sales force selling the assay 2.

The $1.92 billion price is more than twice Tempus's cash pile

Even the maximum cash election tops Tempus's $854 million balance sheet

  • Estimate
$0M$500M$1,000M$1,500M$2,000MTempus cash and securities, Q3 2026$854MMax cash consideration (half of equity value)$960MPersonalis equity value$1,920M
Data
Value
Tempus cash and securities, Q3 2026$854M
Max cash consideration (half of equity value) (estimate)$960M
Personalis equity value$1,920M
USD millions. Cash and marketable securities per Tempus Q3 2026 earnings call; equity value and cash-election mechanics per Personalis merger 425 filing. The maximum cash figure is derived as 50 percent of the $1,920 million equity value.2,3

Tempus's own share price now sets the price it pays

The proxy states whether Tempus elects cash, and whether the 15-day VWAP holds above $48.42 2. Tempus raised 2026 revenue guidance to about $1.60 billion with roughly $65 million of adjusted EBITDA 2, so the quarter is strong; the question is whether it can carry a money-losing target without printing shares at the bottom of a collar it wrote for itself. Deep dive in below to learn more.

Get Deals by email, free

The acquisitions, rounds and contracts that move AI money. In our daily email, every weekday.

Loading TEM

Reader comments

0 comments

    Deals

    Anthropic IPO frees 45% of employee stock in two windows; the rest waits on 60-day preset plans

    Two days before Anthropic prices 825 million shares at up to $1.4 trillion, its insider-supply calendar is finally knowable: 45% of employee stock sells in two windows, and the rest only on preset plans no one can change on a headline.

    Deals

    Generac's fourth 2026 acquisition, a Johannesburg power plant, cost R220 million, seller enX says

    The purchase appears only as an eight-line note in Generac's 10-Q; the R220 million price surfaced in the seller's JSE statement. It is the fourth buy of 2026 as Generac races to serve a $4.5 billion data-center backlog.

    Deals

    Veritone bought 30 days with 1.6 million shares as its $40 million Blue Torch loan waits on $25 million

    The AI software company stretched its convertible maturity 30 days and conditioned a $40 million loan on up to $25 million more from its largest stockholders, while revenue fell 30%. The dilution lands on common shareholders either way.

    Deals

    Palo Alto in talks to pay about $500 million for Clutch Security, near 50 times recurring revenue

    Palo Alto Networks is reported in talks to pay about 50 times Clutch Security's recurring revenue, days after CEO Nikesh Arora explained why he pays up for category winners. Wednesday's results release is where such deals have landed before.

    Deals

    AMD issued 14,978,322 shares, about $547 apiece, to close its $8.2 billion World Labs buy

    The filing prices each share AMD handed over at about $547, more than the $534.06 the stock fetched on closing day. What those shares bought is a world model that opened to everyone last week with no paper, no model card and no published price.

    Deals

    Sequoia Capital's $2 billion Anthropic bet gets its first public mark in the November 19 IPO

    The venture firm Sequoia holds roughly $20 billion of SpaceX and more than $2 billion of Anthropic while dismantling its permanent-capital fund. The next four weeks, Thursday's Anthropic pricing and SpaceX's December 8 lockup expiry, decide how much of that becomes supply.

    Subscribe to TheInference for free